| 000 | 01146 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250515202633.0 | ||
| 264 | 0 | _c20100317 | |
| 008 | 201003s 0 0 eng d | ||
| 022 | _a1744-7631 | ||
| 024 | 7 |
_a10.1517/14728220903540265 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aD'Haese, Jan G | |
| 245 | 0 | 0 |
_aFractalkine/CX3CR1: why a single chemokine-receptor duo bears a major and unique therapeutic potential. _h[electronic resource] |
| 260 |
_bExpert opinion on therapeutic targets _cFeb 2010 |
||
| 300 |
_a207-19 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aChemokine CX3CL1 _xantagonists & inhibitors |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInflammation _xetiology |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aPain _xdrug therapy |
| 650 | 0 | 4 |
_aPancreatic Diseases _xdrug therapy |
| 700 | 1 | _aDemir, Ihsan Ekin | |
| 700 | 1 | _aFriess, Helmut | |
| 700 | 1 | _aCeyhan, Güralp O | |
| 773 | 0 |
_tExpert opinion on therapeutic targets _gvol. 14 _gno. 2 _gp. 207-19 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1517/14728220903540265 _zAvailable from publisher's website |
| 999 |
_c19434701 _d19434701 |
||